<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
  
    <!-- SEO -->
    <meta name="description" content="List of publications for James L. Elia, scientist and tech enthusiast.">
    <meta name="keywords" content="publications, resume, portfolio, James Elia, Yale, scientist, PhD, biology">
    <meta name="author" content="James L. Elia">
    <meta name="robots" content="index, follow">
    <link rel="canonical" href="https://www.jlelia.net/publications">
  
    <!-- Site Icons -->
    <link rel="icon" href="/favicon.ico" type="image/x-icon">
    <link rel="shortcut icon" href="/favicon.ico" type="image/x-icon">
    <link rel="apple-touch-icon" sizes="180x180" href="/apple-touch-icon.png">
    
    <!-- Open Graph Meta Tags -->
    <meta property="og:title" content="James L. Elia">
    <meta property="og:description" content="Online resume and portfolio of James L. Elia, scientist and tech enthusiast.">
    <meta property="og:image" content="https://www.jlelia.net/about/headshot.png">
    <meta property="og:url" content="https://www.jlelia.net/">
    <meta property="og:type" content="website">
    
    <!-- PWA / Mobile Enhancements -->
    <link rel="manifest" href="/site.webmanifest">
    <meta name="theme-color" content="#ffffff">
    
    <!-- Performance Optimizations -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    
    <title>Publications - James L. Elia</title>
    <style>
      body {
        font-family: Arial, sans-serif;
        margin: 0;
        padding: 0;
        display: flex;
        flex-direction: column;
        min-height: 100vh;
	line-height: 1.6;
      }
      header {
        background-color: #333;
        color: white;
        padding: 1rem;
        text-align: center;
      }
      nav {
        margin-top: 1rem;
      }
      nav a {
        color: white;
        text-decoration: none;
        margin: 0 15px;
        font-size: 1.2rem;
      }
      nav a:hover {
        text-decoration: underline;
      }
      main {
        padding: 2rem;
        flex: 1; /* Makes sure the main content area takes up the remaining space */
      }
      .intro {
        background: linear-gradient(135deg, #f9f9f9, #ffffff);
        padding: 2rem;
        border-bottom: 2px solid #ddd;
        margin-bottom: 2rem;
        text-align: left;
        border-radius: 8px;
      }
      .intro h2 {
        font-size: 2rem;
        margin-bottom: 1rem;
        text-align: center;
      }
      .intro p {
        font-size: 1rem;
        line-height: 1.6;
        margin-bottom: 1rem;
      }
      .intro ul {
        list-style: none;
        padding: 0;
        margin: 0;
      }
      .intro ul li {
        font-size: 1rem;
        line-height: 1.6;
        padding: 0.5rem 0;
        border-bottom: 1px solid #eee;
      }
      .intro ul li:last-child {
        border-bottom: none;
      }
      /* New rule: add spacing between each publication */
      section details {
        margin-bottom: 1.5rem;
      }
      /* Optional: add a little visual separation for the section headings */
      section h3 {
        margin-top: 2rem;
        margin-bottom: 1rem;
        border-bottom: 1px solid #ddd;
        padding-bottom: 0.5rem;
      }
      footer {
        background-color: #333;
        color: white;
        text-align: center;
        padding: 1rem;
        margin-top: auto; /* Ensures footer stays at the bottom but does not overlap content */
      }
    </style>  
  </head>
  <body>
    <header>
      <h1>James L. Elia</h1>
      <nav>
        <a href="/">Home</a>
        <a href="/about">About</a>
        <a href="/publications">Publications</a>
        <a href="/projects">Projects</a>
        <a href="/blog">Blog</a>
      </nav>
    </header>
  
    <main>
      <section class="intro">
          <h2>Publications</h2>
          <p>Below is a complete list of my research publications spanning various topics in chemistry, biology, and biomedical sciences. 
             The first section covers peer-reviewed scientific articles while the latter section covers presentations, posters, and other forms of scientific publication.
             Click the item for a drop-down with more information.</p>
      </section>
  
      <section>
        <h3>Peer-Reviewed Research Articles</h3>

        <details>
          <summary>E.D. Huseman, A. Lo, O. Fedorova, <strong>J.L. Elia</strong>, S.E. Gueble, K. Lin, R.K. Sundaram, J. Oh, J. Liu, F. Menges, M.G. Rees, M.M. Ronan, J.A. Roth, V.S. Batista, J.M. Crawford, A.M. Pyle, R.S. Bindra, S.B. Herzon. 
          "<a href="https://doi.org/10.1021/jacs.3c06483">Mechanism of Action of KL-50, a Candidate Imidazotetrazine for the Treatment of Drug-Resistant Brain Cancers</a>".  
          <em>Journal of the American Chemical Society</em>. 30 May 2024.</summary>
          <p>Over half of glioblastoma, a deadly brain cancer, do not express methylguanine methyltransferase (MGMT), an important DNA direct repair enzyme. Tumors lacking MGMT are more sensitive to specific kinds of DNA damage; however, resistance often arises by loss of mismatch repair (MMR), which senses this specific DNA damage and leads to cell death. 
             The Bindra and Herzon Labs developed KL-50 as a novel DNA-damaging agent that is selectively toxic to MGMT-deficient cells regardless of MMR status (<em><a href="https://doi.org/10.1126/science.abn7570">Lin and Gueble et al. 2022</a></em>). Here, we elucidate the mechanism of the molecule in detail and offer chemical explanations for its apparent superiority over a similar DNA-damaging agent, mitozolomide (MTZ).</p>
        </details>

        <details>
          <summary>D.C. Luther, R. Goswami, Y-W. Lee, T. Jeon, R. Huang, <strong>J.L. Elia</strong>, H. Nagaraj, J.J.E. Bijlsma, M. Piest, M.A. Langereis, V.M. Rotello. 
          "<a href="https://pubs.rsc.org/en/content/articlelanding/2023/nr/d2nr06428f">Non-viral vaccination through cationic guanidium polymer-pDNA polyplex mediated gene transfer</a>".  
          <em>Nanoscale</em>. 30 May 2023.</summary>
          <p>Shifting focus towards using the PONI polymer system for nucleic acids delivery, which already have a physiological negative charge due to the phosphate backbone. Interestingly, we found shorter PONI polymers encapsulated nucleic acids more efficiently. We used plasmid DNA delivery as a method of vaccination against Newcastle Disease Virus (NDV). We demonstrated protection against NDV within a few weeks of vaccination in a chicken model.</p>
        </details>
  
        <details>
          <summary>T. Jeon, D.C. Luther, R. Goswami, C. Bell, H, Nagaraj, Y.A. Cicek, R. Huang, J.A. Mas Rosario, <strong>J.L. Elia</strong>, J. Im, Y-W. Lee, Y. Liu, F. Scaletti, M.E. Farkas, J. Mager, V.M. Rotello. 
          "<a href="https://pubs.acs.org/doi/10.1021/acsnano.2c08690">Engineered Polymer-siRNA Polyplexes Provide Effective Treatment of Lung Inflammation</a>".  
          <em>ACS Nano</em>. 14 Feb 2023.</summary>
          <p>Continuing a nucleic acids focus from <em>Luther et al. 2023</em>, we used the PONI system for delivery of siRNA targeting tumor necrosis factor alpha (TNF-α), an inflammatory cytokine, to reduce damaging inflammation in the lungs. We were particularly interested in this model due to the increasing prevalence of COVID-19. Our mouse model of lung inflammation showed a strong response to the siRNA delivery at low doses, temporarily lowering TNF-α and mitigating the immune cascade.</p>
        </details>
  
        <details>
          <summary>D.C. Luther, Y. Lee, H. Nagaraj, V. Clark, T. Jeon, R. Goswami, S. Gopalakrishnan, S. Fedeli, W. Jerome, <strong>J.L. Elia</strong>, and V.M. Rotello. 
          "<a href="https://pubs.acs.org/doi/10.1021/acsnano.1c06768">Cytosolic Protein Delivery Using Modular Biotin-Streptavidin Assembly of Nanocomposites</a>".  
          <em>ACS Nano</em>. 18 Apr 2022.</summary>
          <p>The disadvantage of the <em>Lee et al. 2020</em> E-tag system is the labor-intensive mutagenesis of each protein one wished to deliver. To address this, we made the system more modulable and accessible by biotinylating the E-tag and the protein to be delivered, then complexing both with streptavidin, a tetramer that binds tightly to biotin. Now, any protein could be delivered using our homopolymer system with “mix on the bench” chemistry, circumventing the need for extensive genetic engineering.</p>
        </details>
                    
        <details>
          <summary>S. Fedeli*, J. Im*, S. Gopalakrishnan, <strong>J.L. Elia</strong>, A. Gupta, D. Kim, and V.M. Rotello.
          "<a href="https://pubs.rsc.org/en/content/articlelanding/2021/cs/d0cs00659a">Nanomaterial-based bioorthogonal catalysts in biological environment</a>".  
          <em>Chemical Society Reviews</em>. 15 Nov 2021.</summary>
          <p>We wrote a tutorial review on these use of nanomaterials to enhance the efficacy and safety of transition metal catalysts (TMCs) in biological systems. We also review the potential application of nanomaterial-TMC "nanozymes" in therapeutics and imaging.</p>
        </details>
        <details>
          <summary>Y. Lee, D.C. Luther, R. Goswami, T. Jeon, V. Clark, <strong>J. Elia</strong>, S. Gopalakrishnan, V.M. Rotello.
          "<a href='https://pubs.acs.org/doi/10.1021/jacs.9b12759'>Direct Cytosolic Delivery of Proteins through Coengineering of Proteins and Polymeric Delivery Vehicles</a>".  
          <em>Journal of the American Chemical Society</em>. 12 Feb 2020.</summary>
          <p>We developed a system for delivering biologics directly to the cytosol using a homopolymer called poly(oxanorbornene-imide), or “PONI,” which is made cationic via guanidinium functional groups. Our first approach used site-directed mutagenesis to add glutamates to the C-terminus of proteins (E-tag), giving the protein a bulk negative charge at physiological conditions. The negative E-tag spontaneously complexes with the positive PONI polymer in solution. With the protein encapsulated, the polymer momentarily disrupts the membrane and delivers the protein directly to the cytosol.</p>
        </details>
      </section>
      <section>
        <h3>Posters, Presentations, and Other Publications</h3>

        <details>
          <summary><strong>J.L. Elia</strong>, S. Friedman, R. Bindra.
          "<a href=https://aacrjournals.org/cancerres/article/85/8_Supplement_1/6291/757052/Abstract-6291-CellPyAbility-an-integrated-toolkit?searchresult=1 target=_blank>CellPyAbility: an integrated toolkit for high-throughput cell viability assays and automated analysis</a>".
          <em>American Association of Cancer Researchers Annual Meeting</em>. 29 Apr 2025.</summary>
          <p>Presented a poster at AACR in the New Software and Machine Learning section on a software suite I wrote for analyzing high-throughput drug screens.</p>
        </details>

        <details>
          <summary>C. Heer, S. Johnson, <strong>J.L. Elia</strong>, S. Friedman, X. Pei, S, Arbelaez, R, Sundaram, V. Menon, J. Edmonds, K. Lucas, N. Riaz, S. Gueble, R. Bindra.
          "<a href=https://aacrjournals.org/cancerres/article/85/8_Supplement_1/2902/756587/Abstract-2902-Systematic-mapping-of-chemo-genomic target=_blank>Systematic mapping of chemo-genomic interactions between DNA damaging agents and DNA damage repair genes with targeted CRISPR knockout screening</a>."
          <em>American Association of Cancer Researchers Annual Meeting</em>. 28 Apr 2025.</summary>
          <p>A systems-level analysis of >10,000 chemo-genomic interactions using a DNA-damage response (DDR)-targeted CRISPR knockout screen.</p>
        </details>

        <details>
          <summary><strong>J.L. Elia</strong>, J. Hill, C. Heer, S. Smolev, S. Johnson, K. Lucas, R. Sundaram, R. Bindra, S. Herzon.
          "Exploiting Homologous Recombination Defects with a Novel DNA-Crosslinking Strategy".  
          <em>Radiobiology and Genome Integrity Research Seminar</em>. 3 Mar 2025.</summary>
          <p>Presented my research at Yale Cancer Center's Radiobiology and Genome Integrity Research Seminar on the selective inhibition of homologous recombination deficient tumors using DNA-crosslinking agents.</p>
        </details>

        <details>
          <summary><strong>J.L. Elia</strong>, C. Heer, S. Johnson, K. Lin, S. Smolev, R. Sundaram, R. Bindra, S. Herzon.
          "Exploiting Homologous Recombination Defects with a Novel DNA-Crosslinking Strategy".  
          <em>DNA Damage, Mutation, and Cancer Gordon Research Conference</em>. 10 Mar 2024.</summary>
          <p>Presented a poster on the use of a DNA-crosslinking agent with an exceptional selectivity for tumors lacking functional homologous recombination.</p>
        </details>

        <details>
          <summary>E.D. Huseman, A. Lo, O. Fedorova, <strong>J. Elia</strong>, S. Gueble, K. Lin, R. Sundaram, J. Oh, J. Liu, F. Menges, M. Rees, M. Ronan, J. Roth, V. Batista, J. Crawford, A. Pyle, R. Bindra, S. Herzon.
          "<a href="https://doi.org/10.26434/chemrxiv-2023-zwj94">Mechanism of Action of KL-50, a Novel Imidazotetrazine for the Treatment of Drug-Resistant Brain Cancers</a>".  
          <em>ChemRxiv</em>. 13 June 2023.</summary>
          <p>Preprint. See above manuscript for final version and description.</p>
        </details>

        <details>
          <summary><strong>J.L. Elia</strong>, N. Bartfield, R. Sundaram, R. Bindra, S. Herzon.
          "Exploiting Oncometabolite-driven DNA Repair Deficiencies in Mutant IDH Tumors".  
          <em>Radiobiology and Genome Integrity Research Seminar</em>. 30 Jan 2023.</summary>
          <p>Presented my research at Yale Cancer Center's Radiobiology and Genome Integrity Research Seminar on the inhibition of ALKBH enzymes in mutant-IDH tumors by the accumulation of 2-hydroxyglutarate.</p>
        </details>

        <details>
          <summary><strong>J.L. Elia</strong>, V.M. Rotello.
          "Comparing two delivery systems for efficient in vitro human genome editing".  
          <em>Commonwealth Honors College Thesis in Biology</em>. 15 May 2021.</summary>
          <p>I compared the novel PONI homopolymer and E-tag system to arginine-functionalized gold nanoparticles, the previous delivery system used in the Rotello Lab. By quantifying GFP knockout in modified human cells after nanoparticle-mediated delivery of Cas9 ribonucleoprotein (RNP), we found the 60 kDa PONI homopolymer system to be superior in gene editing efficiency.</p>
        </details>
        
        <details>
          <summary><strong>J.L. Elia</strong>, V.M. Rotello.
          "Comparing two delivery systems for efficient in vitro human genome editing".  
          <em>Massachusetts Undergraduate Research Conference</em>. 23 Apr 2021.</summary>
          <p>Presented my honors thesis of the same title.</p>
        </details>
      </section>
    </main>
  
  
    <footer>
      <p>&copy; 2025 James L. Elia</p>
    </footer>
  </body>
</html>
